Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-1165
Radiotherapy market is forecasted to value over CAGR of over 4% from the forecast period 2022-2028. Improvements and further amendments in image-guided radiotherapy are propelling the market. The rising preference towards radiotherapy procedures for cancer treatment coupled with increasing usage of particle therapy for cancer diagnosis is spurring the market growth. Latest technological advancements in radiotherapy are expected to propel the market. Furthermore, rising incidences of cancer have expanded the market. According to the American Cancer Society, in 2020, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. The rise in research and development activities regarding cancer treatment launched by non-government and government organizations is expected to boost the market. The market is classified into product type, type, application, end-user and region. Based on regions, North America dictates the market growth. Presence of prominent players and developed healthcare infrastructure is boosting the market in the region. Growing cases of cancer and favorable government policies are promoting adoption of radiotherapy, thus positively influencing the market. Asia-Pacific region is expected to be a lucrative region for manufacturers owing to a rapidly improving healthcare infrastructure and growing per capita income in emerging economies like China, Japan and India. In addition, favorable policies launched by the governments of these countries is expected to strengthen market position in the region. Major players included in the Radiotherapy Market: • Accuray Incorporated • C. R. Bard, Inc. • Elekta • Hitachi, LTD. • Iba (Ion Beam Applications Sa) • Isoray Medical, Inc. • Mevion Medical Systems, Inc. • Optivus Proton Therapy, Inc. • Panacea Medical Technologies Pvt. LTD. • P-Cure LTD. • Provision Healthcare, LLC. • Sumitomo Heavy Industries, LTD • Theragenics Corporation • Varian Medical Systems, Inc. • Viewray Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) Competitive Landscape: ● Varian Medical Systems in 2017, opened its centre in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil ● Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans ● Mitsubishi Electric in 2017 decided to transfer its particle therapy systems to Hitachi Radiotherapy Market Segmentation: By Product Type • External Beam Radiotherapy o Linear Accelerators (LINAC) • Conventional Linear Accelerators • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators o Gamma Knife o Cyberknife o Tomotherapy o Particle Therapy Systems • Cyclotrons • Synchrotrons • Synchrocyclotrons o Conventional Cobalt-60 Teletherapy Units • Internal Beam Radiotherapy/Brachytherapy o Seeds o Applicators o Afterloaders o Electronic Brachytherapy Products • Systemic Radiotherapy o Iobenguane (I-131) o Samarium-153 o Rhenium-186 o Other Systemic Radiotherapy Products By Type • External Beam Radiotherapy o Image-Guided Radiotherapy (IMRT) o 3D Conformal Radiotherapy (3D CRT) o Intensity-Modulated Radiotherapy (IMRT) • Volumetric Arc Therapy (VMAT) • Tomotherapy o Stereotactic Therapy o Particle Therapy (Heavy-Ion and Proton Therapy) • Internal Beam Radiotherapy o Low-Dose-Rate (LDR) Brachytherapy o High-Dose-Rate (HDR) Brachytherapy o Pulsed-Dose-Rate (PDR) Brachytherapy • Systemic Radiotherapy o Intravenous Radiotherapy o Oral Radiotherapy o Instillation Radiotherapy By Application • External Beam Radiation Therapy o Prostate Cancer o Breast Cancer o Lung Cancer o Head and Neck Cancer o Colorectal Cancer o Other Cancers • Internal Beam Radiotherapy/Brachytherapy o Prostate Cancer o Gynecological Cancer o Breast Cancer o Cervical Cancer o Penile Cancer o Other Cancers By End User • Hospitals • Independent Radiotherapy Centers By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa FutureWise Key Takeaways ● Growth Prospects ● SWOT Analysis ● Key Trends ● Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on radiotherapy the market by type, by product type, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Improvements and further amendments in image-guided radiotherapy are propelling the market. The rising preference towards radiotherapy procedures for cancer treatment coupled with increasing usage of particle therapy for cancer diagnosis is spurring the market growth. Latest technological advancements in radiotherapy are expected to propel the market. Furthermore, rising incidences of cancer have expanded the market. According to the American Cancer Society, in 2020, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. The rise in research and development activities regarding cancer treatment launched by non-government and government organizations is expected to boost the market.
The market is classified into product type, type, application, end-user and region.
Based on regions, North America dictates the market growth. Presence of prominent players and developed healthcare infrastructure is boosting the market in the region. Growing cases of cancer and favorable government policies are promoting adoption of radiotherapy, thus positively influencing the market.
Asia-Pacific region is expected to be a lucrative region for manufacturers owing to a rapidly improving healthcare infrastructure and growing per capita income in emerging economies like China, Japan and India. In addition, favorable policies launched by the governments of these countries is expected to strengthen market position in the region.
Major players included in the Radiotherapy Market: • Accuray Incorporated • C. R. Bard, Inc. • Elekta • Hitachi, LTD. • Iba (Ion Beam Applications Sa) • Isoray Medical, Inc. • Mevion Medical Systems, Inc. • Optivus Proton Therapy, Inc. • Panacea Medical Technologies Pvt. LTD. • P-Cure LTD. • Provision Healthcare, LLC. • Sumitomo Heavy Industries, LTD • Theragenics Corporation • Varian Medical Systems, Inc. • Viewray Inc. (Note: The list of the major players will be updated with the latest market scenario and trends)
Competitive Landscape: ● Varian Medical Systems in 2017, opened its centre in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil ● Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans ● Mitsubishi Electric in 2017 decided to transfer its particle therapy systems to Hitachi Radiotherapy Market Segmentation:
By Product Type • External Beam Radiotherapy o Linear Accelerators (LINAC) • Conventional Linear Accelerators • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators o Gamma Knife o Cyberknife o Tomotherapy o Particle Therapy Systems • Cyclotrons • Synchrotrons • Synchrocyclotrons o Conventional Cobalt-60 Teletherapy Units • Internal Beam Radiotherapy/Brachytherapy o Seeds o Applicators o Afterloaders o Electronic Brachytherapy Products • Systemic Radiotherapy o Iobenguane (I-131) o Samarium-153 o Rhenium-186 o Other Systemic Radiotherapy Products
By Type • External Beam Radiotherapy o Image-Guided Radiotherapy (IMRT) o 3D Conformal Radiotherapy (3D CRT) o Intensity-Modulated Radiotherapy (IMRT) • Volumetric Arc Therapy (VMAT) • Tomotherapy o Stereotactic Therapy o Particle Therapy (Heavy-Ion and Proton Therapy) • Internal Beam Radiotherapy o Low-Dose-Rate (LDR) Brachytherapy o High-Dose-Rate (HDR) Brachytherapy o Pulsed-Dose-Rate (PDR) Brachytherapy • Systemic Radiotherapy o Intravenous Radiotherapy o Oral Radiotherapy o Instillation Radiotherapy
By Application • External Beam Radiation Therapy o Prostate Cancer o Breast Cancer o Lung Cancer o Head and Neck Cancer o Colorectal Cancer o Other Cancers • Internal Beam Radiotherapy/Brachytherapy o Prostate Cancer o Gynecological Cancer o Breast Cancer o Cervical Cancer o Penile Cancer o Other Cancers
By End User • Hospitals • Independent Radiotherapy Centers
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
FutureWise Key Takeaways ● Growth Prospects ● SWOT Analysis ● Key Trends ● Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on radiotherapy the market by type, by product type, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Radiotherapy Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Radiotherapy Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Radiotherapy Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Radiotherapy Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. External Beam Radiotherapy 7.1.1. Linear Accelerators (LINAC) 7.1.1.1. Conventional Linear Accelerators 7.1.1.2. Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators 7.1.1.2.1. Gamma Knife 7.1.1.2.2. Cyberknife 7.1.1.2.3. Tomotherapy 7.1.2. Particle Therapy Systems 7.1.2.1. Cyclotrons 7.1.2.2. Synchrotrons 7.1.2.3. Synchrocyclotrons 7.1.3. Conventional Cobalt-60 Teletherapy Units 7.2. Internal Beam Radiotherapy/Brachytherapy 7.2.1. Seeds 7.2.2. Applicators 7.2.3. Afterloaders 7.2.4. Electronic Brachytherapy Products 7.3. Systemic Radiotherapy 7.3.1. Iobenguane (I-131) 7.3.2. Samarium-153 7.3.3. Rhenium-186 7.3.4. Other Systemic Radiotherapy Products 8. Global Radiotherapy Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. External Beam Radiotherapy 8.1.1. Image-Guided Radiotherapy (IMRT) 8.1.2. 3D Conformal Radiotherapy (3D CRT) 8.1.3. Intensity-Modulated Radiotherapy (IMRT) 8.1.3.1. Volumetric Arc Therapy (VMAT) 8.1.3.2. Tomotherapy 8.1.4. Stereotactic Therapy 8.1.5. Particle Therapy (Heavy-Ion and Proton Therapy) 8.2. Internal Beam Radiotherapy 8.2.1. Low-Dose-Rate (LDR) Brachytherapy 8.2.2. High-Dose-Rate (HDR) Brachytherapy 8.2.3. Pulsed-Dose-Rate (PDR) Brachytherapy 8.3. Systemic Radiotherapy 8.3.1. Intravenous Radiotherapy 8.3.2. Oral Radiotherapy 8.3.3. Instillation Radiotherapy 9. Global Radiotherapy Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. External Beam Radiation Therapy 9.1.1. Prostate Cancer 9.1.2. Breast Cancer 9.1.3. Lung Cancer 9.1.4. Head and Neck Cancer 9.1.5. Colorectal Cancer 9.1.6. Other Cancers 9.2. Internal Beam Radiotherapy/Brachytherapy 9.2.1. Prostate Cancer 9.2.2. Gynecological Cancer 9.2.3. Breast Cancer 9.2.4. Cervical Cancer 9.2.5. Penile Cancer 9.2.6. Other Cancers 10. Global Radiotherapy Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals 10.2. Independent Radiotherapy Centers 11. North America Radiotherapy Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Radiotherapy Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Radiotherapy Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Radiotherapy Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Accuray Incorporated 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. C. R. Bard, Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Elekta 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Hitachi, LTD. 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Iba (Ion Beam Applications Sa) 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Isoray Medical, Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Mevion Medical Systems, Inc. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Optivus Proton Therapy, Inc. 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Panacea Medical Technologies Pvt. LTD. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. P-Cure LTD. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11. Provision Healthcare, LLC. 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12. Sumitomo Heavy Industries, LTD 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13. Theragenics Corporation 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14. Varian Medical Systems, Inc. 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15. Viewray Inc. 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Radiotherapy Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Radiotherapy Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Radiotherapy Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Radiotherapy Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. External Beam Radiotherapy 7.1.1. Linear Accelerators (LINAC) 7.1.1.1. Conventional Linear Accelerators 7.1.1.2. Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators 7.1.1.2.1. Gamma Knife 7.1.1.2.2. Cyberknife 7.1.1.2.3. Tomotherapy 7.1.2. Particle Therapy Systems 7.1.2.1. Cyclotrons 7.1.2.2. Synchrotrons 7.1.2.3. Synchrocyclotrons 7.1.3. Conventional Cobalt-60 Teletherapy Units 7.2. Internal Beam Radiotherapy/Brachytherapy 7.2.1. Seeds 7.2.2. Applicators 7.2.3. Afterloaders 7.2.4. Electronic Brachytherapy Products 7.3. Systemic Radiotherapy 7.3.1. Iobenguane (I-131) 7.3.2. Samarium-153 7.3.3. Rhenium-186 7.3.4. Other Systemic Radiotherapy Products
8. Global Radiotherapy Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. External Beam Radiotherapy 8.1.1. Image-Guided Radiotherapy (IMRT) 8.1.2. 3D Conformal Radiotherapy (3D CRT) 8.1.3. Intensity-Modulated Radiotherapy (IMRT) 8.1.3.1. Volumetric Arc Therapy (VMAT) 8.1.3.2. Tomotherapy 8.1.4. Stereotactic Therapy 8.1.5. Particle Therapy (Heavy-Ion and Proton Therapy) 8.2. Internal Beam Radiotherapy 8.2.1. Low-Dose-Rate (LDR) Brachytherapy 8.2.2. High-Dose-Rate (HDR) Brachytherapy 8.2.3. Pulsed-Dose-Rate (PDR) Brachytherapy 8.3. Systemic Radiotherapy 8.3.1. Intravenous Radiotherapy 8.3.2. Oral Radiotherapy 8.3.3. Instillation Radiotherapy
9. Global Radiotherapy Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. External Beam Radiation Therapy 9.1.1. Prostate Cancer 9.1.2. Breast Cancer 9.1.3. Lung Cancer 9.1.4. Head and Neck Cancer 9.1.5. Colorectal Cancer 9.1.6. Other Cancers 9.2. Internal Beam Radiotherapy/Brachytherapy 9.2.1. Prostate Cancer 9.2.2. Gynecological Cancer 9.2.3. Breast Cancer 9.2.4. Cervical Cancer 9.2.5. Penile Cancer 9.2.6. Other Cancers
10. Global Radiotherapy Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals 10.2. Independent Radiotherapy Centers
11. North America Radiotherapy Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Radiotherapy Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Radiotherapy Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Radiotherapy Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Accuray Incorporated 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. C. R. Bard, Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Elekta 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Hitachi, LTD. 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Iba (Ion Beam Applications Sa) 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Isoray Medical, Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Mevion Medical Systems, Inc. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Optivus Proton Therapy, Inc. 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Panacea Medical Technologies Pvt. LTD. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. P-Cure LTD. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11. Provision Healthcare, LLC. 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12. Sumitomo Heavy Industries, LTD 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13. Theragenics Corporation 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14. Varian Medical Systems, Inc. 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15. Viewray Inc. 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics